Literature DB >> 8423470

Simultaneous pontine and basal forebrain microinjections of carbachol suppress REM sleep.

H A Baghdoyan1, J L Spotts, S G Snyder.   

Abstract

This study was performed to test the hypothesis that cholinoceptive basal forebrain systems can significantly influence cholinoceptive pontine mechanisms known to be important for generating rapid eye movement (REM) sleep. This hypothesis was examined by microinjecting the cholinergic agonist carbachol or saline (vehicle control) into the pons, the basal forebrain, or simultaneously into the pons and basal forebrain, while quantifying the effects on sleep and wakefulness in unanesthetized, chronically instrumented cats. All microinjections were made during wakefulness and were followed by 2 or 4 hr of recording. Polygraphic records were scored for wakefulness, non-REM sleep, REM sleep, and the REM sleep-like state evoked by pontine administration of carbachol (DCarb). Dependent variables quantified following each microinjection included the percentage of recording time spent in each state, the latency to onset of non-REM, REM, and DCarb, the number of episodes per hour of each state, and the duration of the longest episode of each state. A total of 149 microinjections were made into 15 forebrain and 11 pontine sites in eight cats. Basal forebrain administration of carbachol significantly increased wakefulness. Pontine microinjection of carbachol produced a state that polygraphically and behaviorally resembled REM sleep. This REM sleep-like state occurred in amounts significantly greater than natural REM sleep. Pontine carbachol also significantly decreased wakefulness and non-REM sleep. Simultaneous injection of carbachol into the pons and basal forebrain enhanced REM sleep, but the magnitude of this enhancement was significantly less than the increase in REM sleep evoked by carbachol injection into the pons alone. The results show that cholinoceptive regions of the basal forebrain can increase wakefulness and reduce the ability of pontine carbachol to evoke the REM sleep-like state. These findings suggest that basal forebrain administration of carbachol activates an arousal-generating system that can successfully compete with the powerful cholinergic REM sleep-generating system of the pons.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423470      PMCID: PMC6576316     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  16 in total

1.  A quantitative study of the brainstem cholinergic projections to the ventral part of the oral pontine reticular nucleus (REM sleep induction site) in the cat.

Authors:  Margarita Lucía Rodrigo-Angulo; Elisia Rodríguez-Veiga; Fernando Reinoso-Suárez
Journal:  Exp Brain Res       Date:  2004-09-10       Impact factor: 1.972

2.  Optogenetic activation of cholinergic neurons in the PPT or LDT induces REM sleep.

Authors:  Christa J Van Dort; Daniel P Zachs; Jonathan D Kenny; Shu Zheng; Rebecca R Goldblum; Noah A Gelwan; Daniel M Ramos; Michael A Nolan; Karen Wang; Feng-Ju Weng; Yingxi Lin; Matthew A Wilson; Emery N Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-29       Impact factor: 11.205

3.  Desynchronized (REM) sleep inhibition induced by carbachol microinjections into the nucleus basalis of Meynert is mediated by the glutamatergic system.

Authors:  A Manfridi; M Mancia
Journal:  Exp Brain Res       Date:  1996-04       Impact factor: 1.972

4.  Vasoactive intestinal polypeptide excites medial pontine reticular formation neurons in the brainstem rapid eye movement sleep-induction zone.

Authors:  K A Kohlmeier; P B Reiner
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

5.  Pontine nitric oxide modulates acetylcholine release, rapid eye movement sleep generation, and respiratory rate.

Authors:  T O Leonard; R Lydic
Journal:  J Neurosci       Date:  1997-01-15       Impact factor: 6.167

6.  Neuropathological analysis of brainstem cholinergic and catecholaminergic nuclei in relation to rapid eye movement (REM) sleep behaviour disorder.

Authors:  B N Dugger; M E Murray; B F Boeve; J E Parisi; E E Benarroch; T J Ferman; D W Dickson
Journal:  Neuropathol Appl Neurobiol       Date:  2012-04       Impact factor: 8.090

7.  Intrinsic membrane properties and cholinergic modulation of mouse basal forebrain glutamatergic neurons in vitro.

Authors:  Chun Yang; James T McKenna; Ritchie E Brown
Journal:  Neuroscience       Date:  2017-04-12       Impact factor: 3.590

8.  Chronotype and time-of-day influences on the alerting, orienting, and executive components of attention.

Authors:  Robert L Matchock; J Toby Mordkoff
Journal:  Exp Brain Res       Date:  2008-09-23       Impact factor: 1.972

9.  State-dependent control of lumbar motoneurons by the hypocretinergic system.

Authors:  Jack Yamuy; Simon J Fung; Mingchu Xi; Michael H Chase
Journal:  Exp Neurol       Date:  2009-12-03       Impact factor: 5.330

10.  The nitric oxide synthase inhibitor NG-Nitro-L-arginine increases basal forebrain acetylcholine release during sleep and wakefulness.

Authors:  Jacqueline Vazquez; Ralph Lydic; Helen A Baghdoyan
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.